Are you Dr. Carlisle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 67 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-7714Fax+1 319-353-8377
Summary
- Dr. Thomas Carlisle, MD is an oncologist in Iowa City, Iowa. He is currently licensed to practice medicine in Iowa. He is affiliated with University of Iowa Hospitals and Clinics and is an Associate Professor at University of Iowa College of Medicine.
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1989 - 1992
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1986 - 1989
- University of Missouri-Columbia School of MedicineClass of 1986
Certifications & Licensure
- IA State Medical License 1989 - 2014
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Publications & Presentations
PubMed
- 45 citationsFirst-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed GlioblastomaBryan G. Allen, Kellie L. Bodeker, Mark C. Smith, Varun Monga, Sonia Sandhu
Clinical Cancer Research. 2019-11-15 - 105 citationsOand HO-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.Joshua D Schoenfeld, Zita A Sibenaller, Kranti A Mapuskar, Brett A Wagner, Kimberly L Cramer-Morales
Cancer Cell. 2017-04-10 - 81 citationsErratum: O2 ⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate (Cancer ...Joshua D. Schoenfeld, Zita A. Sibenaller, Kranti A. Mapuskar, Brett A. Wagner, Kimberly L. Cramer-Morales
Cancer Cell. 2017-08-14
Professional Memberships
- Member